Antibody-dependent enhancement of Coronavirus

Antibody-dependent enhancement (ADE) exists in several kinds of virus. It has a negative influence on antibody therapy for viral infection. This effect was first identified in dengue virus and then was also described for coronavirus. The rapid spread of the newly emerged 2019 novel coronavirus (COVI...

Full description

Autores:

Tipo de recurso:

Article of journal

Fecha de publicación:

2020

Institución:

Universidad de Bogotá Jorge Tadeo Lozano

Repositorio:

Expeditio: repositorio UTadeo

Idioma:

eng

OAI Identifier:

oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/13409

Acceso en línea:

https://www.sciencedirect.com/science/article/pii/S1201971220307311
http://hdl.handle.net/20.500.12010/13409
https://doi.org/10.1016/j.ijid.2020.09.015

Palabra clave:

COVID-19
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
Antibody-dependent enhancement (ADE)
2019 novel coronavirus (COVID-19)
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Severe acute respiratory syndrome coronavirus (SARS-CoV)
Middle East respiratory syndrome coronavirus (MERS-CoV)

Rights

License

Abierto (Texto Completo)